PTSD Trial, Recruiting NCT05624931 Sponsor: Boston University Charles River Campus Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05624931
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female and aged 15 or older
  • People who are currently pregnant and receiving antenatal (pregnancy) care at the Gugulethu Midwife Obstetric Unit (MOU)
  • People who are HIV-negative
  • People who either started taking PrEP (a medication that helps prevent HIV) less than one month ago, or who have had difficulty keeping up with their PrEP as prescribed — either shown in clinic records (more than 2 weeks late to collect a refill) or reported by the person themselves
  • People who have moderate to severe symptoms of post-traumatic stress and/or depression, as measured by specific questionnaire scores (confirm with trial site for exact score thresholds)

Who may not be able to join:

  • People who are not able to give informed consent or agreement to participate in English or Xhosa
  • People who have a significant mental health condition, such as an active psychotic disorder or untreated bipolar disorder, that could make participation difficult — research staff will ask some questions to help assess this
  • People who have a health condition that makes it difficult for them to travel to the clinic

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amelia Stanton, PhD, Boston University

Phone: 617-353-2580

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University Charles River Campus
Registry
ClinicalTrials.gov
Start date
17 April 2025
Est. completion
28 February 2027

Where this trial is recruiting

🇿🇦 South Africa 🇺🇸 United States

Primary endpoints

Feasibility of Intervention; Acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov